ClinVar Miner

Submissions for variant NM_000059.4(BRCA2):c.4298G>A (p.Gly1433Glu)

dbSNP: rs758795405
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV000702761 SCV000831629 uncertain significance Hereditary breast ovarian cancer syndrome 2022-11-23 criteria provided, single submitter clinical testing Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt BRCA2 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. ClinVar contains an entry for this variant (Variation ID: 579469). This variant has not been reported in the literature in individuals affected with BRCA2-related conditions. This variant is present in population databases (rs758795405, gnomAD 0.0009%). This sequence change replaces glycine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 1433 of the BRCA2 protein (p.Gly1433Glu).
Quest Diagnostics Nichols Institute San Juan Capistrano RCV000758892 SCV000887809 uncertain significance not provided 2017-10-11 criteria provided, single submitter clinical testing
Ambry Genetics RCV002332491 SCV002626702 uncertain significance Hereditary cancer-predisposing syndrome 2024-06-21 criteria provided, single submitter clinical testing The p.G1433E variant (also known as c.4298G>A), located in coding exon 10 of the BRCA2 gene, results from a G to A substitution at nucleotide position 4298. The glycine at codon 1433 is replaced by glutamic acid, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
University of Washington Department of Laboratory Medicine, University of Washington RCV002332491 SCV003850396 likely benign Hereditary cancer-predisposing syndrome 2023-03-23 criteria provided, single submitter curation Missense variant in a coldspot region where missense variants are very unlikely to be pathogenic (PMID:31911673).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.